Tag: Food & Drug Administration
FDA OKs Long-Acting Atypical Antipsychotic for Schizophrenia
Aristada (aripiprazole lauroxil) is injected every four-to-six weeks
FDA Approves Keytruda for Advanced NSCLC
Approved for use with PD-L1 IHC 22C3 pharmDx test
FDA Approves Two New Medications for Diabetes
Tresiba and Ryzodeg approved for use in adults with type 1 and 2 diabetes mellitus
FDA Approves Lonsurf for Metastatic Colorectal Cancer
For patients with metastatic CRC previously treated with chemotherapy, biological therapy
FDA Approves New Drug for Schizophrenia, Bipolar Disorder
Vraylar is an atypical antipsychotic taken once a day
FDA Orders Tobacco Company to Stop Sales of New Cigarettes
Says products didn't meet requirement that they be substantially the same as existing cigarettes
FDA Announces New Steps to Improve Food Safety in U.S.
New rules focus on cleanliness of manufacturing facilities
FDA Issues Warning Regarding Injectable Skin Lighteners
Injectable products may contain unknown substances or contaminants
FDA Approves Varubi for Chemo-Induced Nausea, Vomiting
For prevention of the delayed phase of nausea, vomiting caused by chemotherapy
FDA Approves Repatha for Certain Patients With High Cholesterol
Approved for patients unable to get LDL cholesterol under control with current treatment options
